BMS launches selective cardiac myosin inhibitor drug in India – The Hindu(Soban News)

1. BMS launches selective cardiac myosin inhibitor drug in India  The Hindu
2. Bristol Myers Squibb launches heart med Mavacamten in India  ET Pharma
3. Bristol Myers Squibb Launches Kopozgo in India as First Oral Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy  geneonline.com
4. Bristol Myers Squibb launches Kopozgo® (Mavacamten) in India for treatment of symptomatic Obstructive Hypertrophic Cardiomyopathy  BioSpectrum India
5. Bristol Myers Squibb launches Kopozgo (Mavacamten) in India for obstructive hypertrophic cardiomyopathy  Express Pharma

​BMS launches selective cardiac myosin inhibitor drug in India  The HinduBristol Myers Squibb launches heart med Mavacamten in India  ET PharmaBristol Myers Squibb Launches Kopozgo in India as First Oral Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy  geneonline.comBristol Myers Squibb launches Kopozgo® (Mavacamten) in India for treatment of symptomatic Obstructive Hypertrophic Cardiomyopathy  BioSpectrum IndiaBristol Myers Squibb launches Kopozgo (Mavacamten) in India for obstructive hypertrophic cardiomyopathy  Express Pharma by Soban News (international And National News)